MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

MDT

97.5

-1.35%↓

A

142.16

-2.52%↓

VEEV

221.22

+1.05%↑

HQY

87.37

+0.44%↑

NEOG

9.33

-2.1%↓

Search

IQVIA Holdings Inc

Open

SectorHealthcare

239.89 -0.49

Overview

Share price change

24h

Current

Min

237.8

Max

242.31

Key metrics

By Trading Economics

Income

66M

332M

Sales

83M

4.1B

P/E

Sector Avg

33.131

90.831

Profit margin

8.098

Employees

91,000

EBITDA

102M

883M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+6.93% upside

Dividends

By Dow Jones

Next Earnings

5 Feb 2026

Market Stats

By TradingEconomics

Market Cap

3.5B

41B

Previous open

240.38

Previous close

239.89

News Sentiment

By Acuity

28%

72%

62 / 361 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

IQVIA Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

15 Jan 2026, 18:44 UTC

Major Market Movers

Agenus Falls After $141 Million Zydus Deal Closes

15 Jan 2026, 17:51 UTC

Major Market Movers

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15 Jan 2026, 17:25 UTC

Major Market Movers

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15 Jan 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 Jan 2026, 23:48 UTC

Market Talk

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15 Jan 2026, 23:40 UTC

Market Talk

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15 Jan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

15 Jan 2026, 23:11 UTC

Market Talk

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15 Jan 2026, 23:01 UTC

Market Talk

New Zealand's Economy Enters An Upswing -- Market Talk

15 Jan 2026, 22:56 UTC

Market Talk
Earnings

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15 Jan 2026, 22:51 UTC

Market Talk

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15 Jan 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15 Jan 2026, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 Jan 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Energy & Utilities Roundup: Market Talk

15 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15 Jan 2026, 21:27 UTC

Earnings

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15 Jan 2026, 21:15 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Commodities Roundup: Market Talk

15 Jan 2026, 21:11 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

15 Jan 2026, 21:11 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15 Jan 2026, 20:10 UTC

Market Talk

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15 Jan 2026, 20:04 UTC

Earnings

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15 Jan 2026, 20:03 UTC

Market Talk

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15 Jan 2026, 19:26 UTC

Market Talk

Silver Closes at Fresh High -- Market Talk

15 Jan 2026, 18:29 UTC

Major Market Movers

Agenus Falls After $141M Zydus Deal Closes

15 Jan 2026, 18:20 UTC

Earnings

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15 Jan 2026, 17:56 UTC

Market Talk
Earnings

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15 Jan 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Auto & Transport Roundup: Market Talk

15 Jan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 Jan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15 Jan 2026, 17:02 UTC

Acquisitions, Mergers, Takeovers

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Peer Comparison

Price change

IQVIA Holdings Inc Forecast

Price Target

By TipRanks

6.93% upside

12 Months Forecast

Average 258.31 USD  6.93%

High 290 USD

Low 215 USD

Based on 15 Wall Street analysts offering 12 month price targets forIQVIA Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

12

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

150.68 / 153.45Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

62 / 361 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat